Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cullinan Therapeutics

8.79
+0.27003.17%
Post-market: 8.790.00000.00%16:05 EDT
Volume:396.78K
Turnover:3.50M
Market Cap:514.33M
PE:-2.82
High:8.97
Open:8.56
Low:8.50
Close:8.52
Loading ...
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2022

Major Issues Report

8-K - Current report
Oct 25, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 27, 2022

Major Issues Report

8-K - Current report
Jun 24, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2022

Major Issues Report

8-K - Current report
Mar 17, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2022

Major Issues Report

8-K - Current report
Mar 10, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals